DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN ASIAN PATIENTS WITH ATRIAL FIBRILLATION
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: PAN, Jean Yun-Ching (Taiwan Society of Health-System Pharmacists/ Taipei Hospital, Ministry of Health and Welfare, New Taipei City, China Taiwan)
- Co-author(s): Jean Yun-Ching Pan
Stroke is a disabling complication of atrial fibrillation (AF) that affects a large number of people in the Asia-Pacific region. For the past 50 years the vitamin K antagonist warfarin has been gold standard therapy. However, the use of warfarin in Asian patients is often suboptimal.
This study identified recently published clinical literature.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.